Evaluation of a Novel Indoor Air Pollution Intervention Among Older Adults

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55-79
SponsorUniversity of Montana

About this trial

Particulate matter air pollution is the leading environmental risk factor of cardiovascular disease and is increasing in the Western United States due to more frequent and severe wildfires. Older adults are particularly susceptible to both air pollution exposures and the development of cardiovascular disease, and the older adult population in the United States is rapidly growing. Given the converging threats of worsening air quality and an aging population, this clinical trial will evaluate a novel, multifaceted indoor air quality intervention to improve cardiovascular health outcomes among older adults in the wildfire-impacted state of Montana.

Eligibility criteria

Qualifiers

55-79 years of age one primary residence (5+ days per week)

have an electronic device, email address, and reliable internet at home for survey submission

Disqualifiers

current smoking of any kind or living in a household with someone who currently smokes

current use of a portable air cleaner unit at home

plans to move in the next year

previous physician-diagnosed cardiovascular disease (coronary heart disease [myocardial infarction], stroke, or heart failure)

Trial design

Treatments tested in this trial

  • Air Improvement and Real-time Monitoring for Wellness through Interactive Strategies and Education (AIRWISE)
  • Portable Air Cleaner (PAC) Control

Treatment groups

154 Participants
are divided into 2 treatment groups

Sponsors and collaborators